These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification. Shah SU; Kaliki S; Kim HJ; Lally SE; Shields JA; Shields CL Arch Ophthalmol; 2012 Feb; 130(2):159-64. PubMed ID: 22332208 [TBL] [Abstract][Full Text] [Related]
8. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up. Krilis M; Tsang H; Coroneo M Ophthalmology; 2012 Oct; 119(10):1969-73. PubMed ID: 22704834 [TBL] [Abstract][Full Text] [Related]
13. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia. Vann RR; Karp CL Ophthalmology; 1999 Jan; 106(1):91-7. PubMed ID: 9917787 [TBL] [Abstract][Full Text] [Related]
14. Etanercept for psoriasis: two case reports. Fidalgo A; Baptista J; Rocha Páris F; Caldas Lopes L; Ferreira A Int J Clin Pharmacol Res; 2005; 25(4):159-63. PubMed ID: 16402631 [TBL] [Abstract][Full Text] [Related]
15. Ocular surface squamous neoplasia treated with topical interferon α 2b. Pujari A BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28100578 [No Abstract] [Full Text] [Related]
16. Topical medical therapies for ocular surface tumors. Poothullil AM; Colby KA Semin Ophthalmol; 2006; 21(3):161-9. PubMed ID: 16912014 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of 9 squamous epithelial carcinoma in situ lesions of the conjunctiva (CIN) with mitomycin C eyedrops in cytological and DNA image cytometric control]. Cartsburg O; Kersten A; Sundmacher R; Nadjari B; Pomjanski N; Böcking A Klin Monbl Augenheilkd; 2001 Jun; 218(6):429-34. PubMed ID: 11488009 [TBL] [Abstract][Full Text] [Related]
18. National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents. Doherty SD; Van Voorhees A; Lebwohl MG; Korman NJ; Young MS; Hsu S; National Psoriasis Foundation J Am Acad Dermatol; 2008 Aug; 59(2):209-17. PubMed ID: 18485527 [TBL] [Abstract][Full Text] [Related]